We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$1.84B
AUM Growth
+$263M
Cap. Flow
+$267M
Cap. Flow %
14.5%
Top 10 Hldgs %
35.28%
Holding
459
New
14
Increased
139
Reduced
189
Closed
18

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.3M
2
MSFT icon
Microsoft
MSFT
+$26.5M
3
JPM icon
JPMorgan Chase
JPM
+$23.4M
4
NEE icon
NextEra Energy
NEE
+$19.5M
5
EMR icon
Emerson Electric
EMR
+$16.7M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$2.05M
2
CVS icon
CVS Health
CVS
+$2.04M
3
RIO icon
Rio Tinto
RIO
+$1.75M
4
DVN icon
Devon Energy
DVN
+$1.73M
5
NKE icon
Nike
NKE
+$1.46M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Financials 13.48%
3 Industrials 11.26%
4 Healthcare 9.64%
5 Consumer Discretionary 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXR icon
401
Extra Space Storage
EXR
$30.8B
$251K 0.01%
1,677
STT icon
402
State Street
STT
$51B
$250K 0.01%
2,549
GWW icon
403
W.W. Grainger
GWW
$60.7B
$250K 0.01%
237
XBI icon
404
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$248K 0.01%
2,755
+75
+3% +$7.27K
FQAL icon
405
Fidelity Quality Factor ETF
FQAL
$1.46B
$248K 0.01%
3,785
AXP icon
406
American Express
AXP
$229B
$245K 0.01%
826
MAS icon
407
Masco
MAS
$14.8B
$245K 0.01%
3,370
IVW icon
408
iShares S&P 500 Growth ETF
IVW
$77.7B
$244K 0.01%
2,400
EW icon
409
Edwards Lifesciences
EW
$53B
$243K 0.01%
3,283
-486
-13% -$34K
GD icon
410
General Dynamics
GD
$107B
$241K 0.01%
916
CEF icon
411
Sprott Physical Gold and Silver Trust
CEF
$8.15B
$238K 0.01%
10,000
TRP icon
412
TC Energy
TRP
$65.3B
$236K 0.01%
+5,075
New +$240K
CCI icon
413
Crown Castle
CCI
$31.4B
$236K 0.01%
2,599
-229
-8% -$23.9K
VMC icon
414
Vulcan Materials
VMC
$36.8B
$232K 0.01%
900
BHP icon
415
BHP
BHP
$231B
$229K 0.01%
4,690
-1,000
-18% -$54.4K
EEMV icon
416
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.55B
$227K 0.01%
3,922
-38
-1% -$2.3K
CTVA icon
417
Corteva
CTVA
$51.3B
$227K 0.01%
3,987
CI icon
418
Cigna
CI
$73.8B
$226K 0.01%
818
-700
-46% -$223K
IWV icon
419
iShares Russell 3000 ETF
IWV
$20.4B
$226K 0.01%
675
CHTR icon
420
Charter Communications
CHTR
$17.9B
$221K 0.01%
645
-3
-0.5% -$1.08K
MCHP icon
421
Microchip Technology
MCHP
$44.3B
$220K 0.01%
3,842
VXF icon
422
Vanguard Extended Market ETF
VXF
$31.9B
$220K 0.01%
+1,157
New +$223K
WPC icon
423
W.P. Carey
WPC
$16B
$215K 0.01%
3,950
CLX icon
424
Clorox
CLX
$13B
$211K 0.01%
1,300
BAX icon
425
Baxter International
BAX
$14.4B
$210K 0.01%
7,186
-375
-5% -$12.6K

Similar funds

Parsons Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Parsons Capital Management held 459 positions worth $1.84B, up 17% from $1.58B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parsons Capital Management deployed $267M of net new capital in Q4 2024, opening 14 new positions and adding to 139 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 254,121 shares worth $6.47M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $2.05M trimmed.

  • Parsons Capital Management's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 254,121 shares worth $6.47M.
  • Parsons Capital Management added most to Apple in Q4 2024, an estimated $28.3M increase.
  • Parsons Capital Management's biggest Q4 2024 reduction was Relmada Therapeutics, cutting an estimated $2.05M.
  • Parsons Capital Management fully exited CVS Health in Q4 2024, selling an estimated $2.04M.
  • Parsons Capital Management's ten largest holdings make up 35% of its $1.84B portfolio in Q4 2024.
  • Parsons Capital Management opened 14 new positions and closed 18 in Q4 2024.
  • Parsons Capital Management's portfolio value rose 17% quarter-over-quarter to $1.84B.

Based on Parsons Capital Management's 13F filing for Q4 2024, filed 22 Jan 2025.